Filter Results :

Your search for Pharmaceuticals returned 5400 reports

Sort by


Vietnam Pharmaceuticals and Healthcare Report

27 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Leveraging Vietnam's National Expanded Immunisation Programme (EPI) will be of strategic benefit to multinational pharmaceutical firms with a strong vaccines portfolio. Government support for the initiative is expected to remain strong, which bodes well for firms as the EPI alleviate...

$ 1,295.00

Read More

Zambia Pharmaceuticals and Healthcare Report

27 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Zambian government will continue to boost social expenditure as President Lungu attempts to gain public favour in light of the August general elections. Fiscal revenues will increase gradually, in line with the copper sector's slow recovery, but real GDP growth in Zambia will sti...

$ 1,295.00

Read More

Arena Pharmaceuticals, Inc. (ARNA) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Arena Pharmaceuticals, Inc. (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and w...

$ 125.00

Read More

Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and...

$ 125.00

Read More

Alnylam Pharmaceuticals, Inc. (ALNY) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Alnylam Pharmaceuticals, Inc. (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and...

$ 125.00

Read More

Progenics Pharmaceuticals, Inc. (PGNX) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Progenics Pharmaceuticals, Inc. (PGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths a...

$ 125.00

Read More

Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
Acadia Pharmaceuticals Inc. (ACAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and w...

$ 125.00

Read More

CASI Pharmaceuticals Inc. (CASI) - Financial and Strategic SWOT Analysis Review

19 Jul 2016  |  Published by:  GlobalData
CASI Pharmaceuticals Inc. (CASI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and wea...

$ 125.00

Read More

Asia Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Asia is a key growth opportunity for pharmaceutical firms. The sector's growth is supported by a solid economic foundation, projected to outperform with an average real GDP growth of 5% as compared to 3% globally over the next five years. Economically, South East Asia is set to be...

$ 1,295.00

Read More

Europe Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Europe will remain the most attractive region for multinational pharmaceutical firms over the coming years. The Western European region is defined by highly developed markets with significant demand for both patented and generic medicines. Emerging Europe represents significant gr...

$ 1,295.00

Read More

Global Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Pharmaceutical companies will face an increasing number of external risks to their operations. Many of these new challenges emanate from the global financial crisis of 2007/08. In an era of fiscal pressures, governments are seeking to control growth in healthcare spending and will...

$ 1,295.00

Read More

Taiwan Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Cross-strait relations will be an important factor influencing the prospects of Taiwan's pharmaceutical industry. The country's medicine exports to China have grown substantially and now account for 14% of the total value, ahead of its exports to Japan and South Korea. Growth pros...

$ 1,295.00

Read More

Philippines Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Philippine pharmaceutical market is relatively small considering its large population and disease burden. Low government spending on healthcare, which falls below the WHO's global standards, and low-income levels limit opportunities for innovative drugmakers. The expansion of ...

$ 1,295.00

Read More

Netherlands Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Netherlands has a well establish pharmaceutical and healthcare sector. In 2016, the pharmaceutical market will face yet another year of contraction in value terms before returning to growth in 2017. Medicine sales will be driven by an ageing population and high per capita spen...

$ 1,295.00

Read More

Poland Pharmaceuticals and Healthcare Report

13 Jul 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Poland will remain one of the most attractive pharmaceutical and healthcare markets in the CEE region. Strong economic growth and the introduction of a tax-funded healthcare system will support strong market growth. Opportunities for innovative drugmakers will be significant, with...

$ 1,295.00

Read More
Total 5400 records.